FDA Device Intelligence
HomeDRG Instruments Gesellschaft mit beschränkter Haftung › Insulin ELISA

Insulin ELISA

DRG Instruments Gesellschaft mit beschränkter Haftung · Model EIA-2935 · UDI-DI 04048474029352

CFP Prescription
10
510(k) clearances
102
Adverse events
8
Recalls
37
Facilities

Description

The DRG Insulin ELISA is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of Insulin in serum and plasma (lithium heparin or EDTA plasma).

Recalls

DateFirmReason
2024-10-07DRG International, Inc.The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of s
2023-11-21Beckman Coulter, Inc.There is an issue with the Access Ultrasensitive Insulin assay protocol file (APF) for use with the DxI 9000 Access Immunoassay Analyzer (APF 182 test definition version 6.7 and be
2018-03-05Tosoh Bioscience IncAsfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.
2017-04-05Siemens Healthcare Diagnostics, IncCurrent lots of ADVIA Centaur/XP/XPT/CP Insulin (IRI) assay recover approximately 40% higher than the World Health Organization (WHO) 1st IRP 66/304 standardization based on slope
2012-04-30Siemens Healthcare DiagnosticsSiemens Healthcare Diagnostics has observed a negative bias in the Immulite Insulin assay.
2012-04-30Siemens Healthcare DiagnosticsSiemens Healthcare Diagnostics has observed a negative bias in the Immulite Insulin assay.
2007-09-19Beckman Coulter IncFalse negative results when used to test serum samples (as compared to plasma samples).
2004-11-19Diagnostic Products CorpLow bias of 10 to 40% at different levels of insulin in samples.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.